Full Text
PCN51 PROJECTED LONG-TERM ECONOMIC OUTCOMES ASSOCIATED WITH BEVACIZUMAB TREATMENT IN PATIENTS WITH ADJUVANT TRIPLENEGATIVE BREAST CANCER TO INFORM EARLY DECISION MAKING

Abstract

Authors

JA Ray E Sabate

Back to Volume 12, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×